Tranzyme Pharma Announces Top-Line Results of TZP-102 Phase 2b Trial
November 15, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
Preliminary Analysis Indicates Trial Did Not Meet Primary Endpoint
Tranzyme to Host Conference Call Today at 8:00 am ET
RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2012 (GLOBE NEWSWIRE) -- ...
Tranzyme Pharma Announces Third Quarter 2012 Financial Results
November 08, 2012 16:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012
October 25, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...